Profile data is unavailable for this security.
About the company
Chengdu Easton Biopharmaceuticals Co Ltd is a China-based company mainly engaged in the research, development, production and sales of chemical raw materials and chemical pharmaceutical preparations. The Company's main products are generic chemical drugs, including nalmefene hydrochloride injection, ibuprofen injection, bisoprolol fumarate tablets and ubenimex. The products are used in anesthesia and analgesia, cardiovascular and cerebrovascular, anti-tumor and endocrine applications. The Company distributes its products in/within the domestic market and to overseas markets.
- Revenue in CNY (TTM)1.33bn
- Net income in CNY241.37m
- Incorporated2009
- Employees1.52k
- LocationChengdu Easton Biopharmaceuticals Co LtdNo. 8 Ankang Road, Shuangliu DistrictCHENGDU 610219ChinaCHN
- Phone+86 2 886106668
- Fax+86 2 862321999
- Websitehttp://www.eastonpharma.cn
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liaoning Chengda Biotechnology Co Ltd | 1.47bn | 177.94m | 10.67bn | 1.81k | 59.19 | 1.14 | -- | 7.26 | 0.433 | 0.433 | 3.56 | 22.54 | 0.1482 | 0.6786 | 1.24 | 813,192.10 | 1.79 | 8.07 | 1.86 | 8.36 | 79.03 | 84.98 | 12.11 | 35.75 | 19.28 | -- | 0.0013 | 44.77 | -4.22 | -0.0082 | -26.42 | -13.26 | -4.72 | -- |
| Jiangsu Sinopep Allsin Bphrmctcl Co Ltd | 1.90bn | 498.69m | 10.68bn | 2.03k | 21.17 | 3.43 | -- | 5.62 | 1.60 | 1.60 | 6.13 | 9.84 | 0.3413 | 0.9306 | 3.06 | 936,748.90 | 8.90 | 7.19 | 13.04 | 9.67 | 66.64 | 59.30 | 26.08 | 20.28 | 0.928 | 16.07 | 0.4604 | 35.89 | 57.21 | 34.33 | 148.19 | 52.76 | 31.58 | -- |
| Aurisco Pharmaceutical Co Ltd | 1.62bn | 424.54m | 10.78bn | 1.78k | 25.08 | 4.24 | -- | 6.63 | 1.06 | 1.06 | 4.07 | 6.26 | 0.4188 | 1.09 | 4.41 | 910,578.10 | 10.94 | 11.37 | 12.60 | 13.29 | 59.77 | 52.93 | 26.13 | 22.34 | 3.01 | 635.15 | 0.2806 | 31.53 | 16.89 | 20.47 | 22.59 | 13.77 | 49.45 | -- |
| Chengdu Olymvax Biopharmaceuticals Inc | 709.13m | 64.21m | 11.01bn | 470.00 | 170.94 | 11.47 | -- | 15.52 | 0.1587 | 0.1587 | 1.75 | 2.36 | 0.3883 | 0.654 | 1.19 | 1,508,792.00 | 3.45 | 3.25 | 5.00 | 4.81 | 92.66 | 93.62 | 8.88 | 8.11 | 1.42 | 8.30 | 0.2906 | 7.39 | 18.69 | 26.88 | 18.24 | -- | 48.00 | -- |
| Shanghai Yizhong Pharmaceutical Co Ltd | 247.05m | 22.96m | 11.02bn | 65.00 | 471.02 | 7.54 | -- | 44.60 | 0.1132 | 0.1132 | 1.22 | 7.07 | 0.163 | 0.9556 | 2.26 | 3,800,801.00 | 1.51 | 5.44 | 1.58 | 5.64 | 81.39 | 92.99 | 9.30 | 36.90 | 7.84 | -- | 0.00 | 32.30 | -51.83 | -- | -95.68 | -- | 10.96 | -- |
| Cansino Biologics Inc | 971.83m | -142.03m | 11.23bn | 1.11k | -- | 2.99 | -- | 11.55 | -0.5455 | -0.5455 | 3.92 | 21.37 | 0.1271 | 0.5861 | 1.38 | 879,482.50 | -1.86 | -4.08 | -2.29 | -5.38 | 78.80 | 45.31 | -14.62 | -27.51 | 3.29 | -- | 0.2242 | -- | 137.01 | 226.43 | 74.45 | -- | 31.38 | -- |
| Zhejiang CONBA Pharmaceutical Co., Ltd. | 6.58bn | 687.99m | 11.23bn | 8.26k | 16.62 | 1.58 | -- | 1.71 | 0.2665 | 0.2665 | 2.54 | 2.80 | 0.6617 | 2.57 | 4.70 | 796,529.00 | 7.13 | 8.51 | 9.65 | 12.74 | 51.88 | 58.64 | 10.77 | 14.12 | 1.38 | -- | 0.0532 | 41.54 | -3.23 | -0.7594 | 5.21 | -- | 1.57 | -- |
| Chengdu Easton Biopharmaceuticals Co Ltd | 1.33bn | 241.37m | 11.37bn | 1.52k | 46.91 | 3.97 | -- | 8.55 | 1.37 | 1.37 | 7.55 | 16.23 | 0.3809 | 1.83 | 5.89 | 873,161.50 | 6.92 | 8.09 | 8.44 | 9.82 | 71.90 | 81.72 | 18.16 | 20.10 | 3.12 | -- | 0.0444 | 30.37 | 20.82 | 7.34 | 5.15 | 17.01 | 4.24 | -- |
| Mayinglong Pharmaceutical Group Co Ltd | 3.77bn | 571.60m | 11.66bn | 2.65k | 20.39 | 2.71 | -- | 3.09 | 1.33 | 1.33 | 8.75 | 9.97 | 0.7211 | 6.23 | 11.99 | 1,421,812.00 | 11.38 | 10.77 | 13.82 | 13.35 | 46.77 | 42.40 | 15.78 | 14.39 | 4.58 | -- | 0.0226 | 37.31 | 18.85 | 6.62 | 19.14 | 7.97 | 34.47 | 18.98 |
| Jiangxi Tianxin Pharmaceutical Co Ltd | 2.23bn | 617.04m | 11.82bn | 2.68k | 19.07 | 2.47 | -- | 5.31 | 1.42 | 1.42 | 5.11 | 10.93 | 0.3973 | 2.43 | 9.65 | 830,883.10 | 11.01 | 17.10 | 11.88 | 21.16 | 43.04 | 42.99 | 27.72 | 30.12 | 4.31 | -- | 0.0721 | 24.41 | 17.35 | 1.75 | 36.85 | -2.20 | 35.06 | -- |
Data as of Feb 13 2026. Currency figures normalised to Chengdu Easton Biopharmaceuticals Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
10.44%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Bosera Asset Management Co., Ltd.as of 30 Jun 2025 | 6.61m | 3.74% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 2.80m | 1.59% |
| Cathay Securities Investment Trust Co., Ltd.as of 31 Mar 2025 | 2.32m | 1.32% |
| China Fund Management Co., Ltd.as of 30 Jun 2025 | 2.15m | 1.22% |
| CCB Principal Asset Management Co., Ltd.as of 30 Jun 2025 | 1.13m | 0.64% |
| Guotai Asset Management Co., Ltd.as of 30 Jun 2025 | 919.76k | 0.52% |
| CIB Fund Management Co., Ltd.as of 30 Jun 2025 | 713.87k | 0.40% |
| ABC-CA Fund Management Co., Ltd.as of 30 Jun 2025 | 634.85k | 0.36% |
| First Seafront Fund Management Co., Ltd.as of 30 Jun 2025 | 580.35k | 0.33% |
| First-Trust Fund Management Co., Ltd.as of 30 Jun 2025 | 557.13k | 0.32% |
More ▼
Data from 30 Jun 2025 - 12 Feb 2026Source: FactSet Research Systems Inc.
